| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3294025 | Gastroenterology | 2012 | 19 Pages |
Abstract
miR-26a promotes cholangiocarcinoma growth by inhibition of GSK-3β and subsequent activation of β-catenin. These signaling molecules might be targets for prevention or treatment of cholangiocarcinoma.
Keywords
mRNA15-PGDHSCIDGSK-3βTCFPGE2qRT-PCRCTDCOX-215-hydroxyprostaglandin dehydrogenasemessenger RNAsmall interfering RNAssiRNAC-terminal domainBiliary tractCyclooxygenase-2lymphoid enhancer factorT cell factorLefUTR یا untranslated regions untranslated regionMicroRNAMiRNAQuantitative reverse transcriptase polymerase chain reactionProstaglandin E2prostaglandinGlycogen synthase kinase-3β
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jinqiang Zhang, Chang Han, Tong Wu,